EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
Conditions
- Metastatic Lung Non-Small Cell Carcinoma
- Advanced Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Stage IVA Lung Cancer AJCC v8
- Stage IVB Lung Cancer AJCC v8
- Stage III Lung Cancer AJCC v8
- Stage IIIA Lung Cancer AJCC v8
- Stage IIIB Lung Cancer AJCC v8
- EGFR Mutation-Related Tumors
Interventions
- DRUG: EMB-01
- DRUG: Osimertinib
Sponsor
Shanghai EpimAb Biotherapeutics Co., Ltd.
Collaborators